Rectal Diseases

24 registered clinical trials studyying Rectal Diseases — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and NCT07351071	Medtronic - MITG	N/A
Recruiting	Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy NCT07222800	Pfizer	Phase 3
Recruiting	Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury NCT06325982	Fujian Cancer Hospital	N/A
Recruiting	SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids NCT05782010	Developeration AB	N/A
Completed	A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemothera NCT06048146	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Active Not Recruiting	CRC Detection Reliable Assessment With Blood NCT05551052	New Day Diagnostics	—
Unknown	Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Ana NCT04887818	University of Calgary	Phase 2 / Phase 3
Unknown	Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Un NCT05322486	State Scientific Centre of Coloproctology, Russian Federation	—
Withdrawn	Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer NCT03633539	Ruijin Hospital	N/A
Completed	Prevention of Colorectal Cancer Through Multiomics Blood Testing NCT04369053	Freenome Holdings Inc.	—
Active Not Recruiting	ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial NCT04084249	Claus Lindbjerg Andersen	N/A
Unknown	Comparison of Rubber Band Ligation and Haemorrhoidectomy in Patients With Symptomatic Haemorrhoids Grade III NCT04621695	Proctos Kliniek	N/A
Completed	Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients NCT04080843	Zhejiang University	Phase 2
Completed	Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma NCT03559543	Catalysis SL	Phase 2
Completed	BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities NCT03072472	South Tyneside and Sunderland NHS Foundation Trust	N/A
Completed	Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and NCT02486094	Royal Marsden NHS Foundation Trust	—
Completed	Early Mobilization After Colorectal Surgery NCT02131844	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
Completed	Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness NCT01816607	University Hospital, Akershus	—
Unknown	Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous In NCT01995942	Royal Marsden NHS Foundation Trust	—
Completed	Prediction of Postoperative Outcomes After Rectal Resection by the Comprehensive Complication Index (CCI) NCT07037693	Cantonal Hospital of St. Gallen	—
Completed	Assessing Infectious Risk and Visceral Closure in Natural Orifice Translumenal Endoscopic Surgery (NOTES) NCT01102725	University Hospitals Cleveland Medical Center	—
Unknown	Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks NCT01037049	Royal Marsden NHS Foundation Trust	Phase 2
Unknown	Low Rectal Cancer Study (MERCURY II) NCT02005965	Royal Marsden NHS Foundation Trust	—
Completed	Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery NCT00487409	University Hospitals Cleveland Medical Center	N/A